SCHEMBL1754848

SCHEMBL1754848

COC(OC)C(=O)Nc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
ALDH1A1 P00352 4/20 0.55
MAPT P10636 4/20 0.55
KMT2A Q03164 4/20 0.55
GAA P10253 3/20 0.55
MEN1 O00255 3/20 0.55
ATM Q13315 2/20 0.55
LMNA P02545 2/20 0.55
RXFP1 Q9HBX9 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.53
HSD17B10 Q99714 2/20 0.52
NAPRT Q6XQN6 1/20 0.52
HSP90AA1 P07900 2/20 0.51
GPR55 Q9Y2T6 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HDAC2 Q92769 2/20 0.50
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.50
EPHX1 P07099 1/20 0.50
EPHX2 P34913 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27432172 0.94 TAAR1 (0.56) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL7978304 0.82 KLK7 (0.61) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL8927647 0.82 POLB (0.53) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL9515695 0.81 MAPT (0.56) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL8927298 0.81 ALDH1A1 (0.61) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL6973912 0.81 POLB (0.52) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL8049390 0.81 ALDH1A1 (0.77) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL16713399 0.79 KLK7 (0.57) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL587395 0.79 MAPT (0.59) POLBALDH1A1MAPTKMT2AGAA
SCHEMBL27799414 0.79 KMT2A (0.56) ALDH1A1MAPTKMT2AGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831153-A2 COMPOUNDS DERIVED FROM LIDOCAINE, PHARMACEUTICAL COMPOSITIONS, USE AND METHOD OF TREATMENT, PREVENTION OR INHIBITION OF DISEASES FUNDA AO OSWALDO CRUZ-FIOCRUZ (BR) 2007-09-12 EP claimed
CN-1989099-A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases FUNDACAO OSWALDO CRUZ (BR) 2007-06-27 CN claimed
WO-2005120148-A2 COMPOUNDS DERIVED FROM LIDOCAINE, PHARMACEUTICAL COMPOSITIONS, USE AND METHOD OF TREATMENT, PREVENTION OR INHIBITION OF DISEASES FUNDAÇÃO OSWALDO CRUZ-FIOCRUZ (BR) 2005-12-22 WO claimed
CN-113474156-B Polyamic acid resin composition, polyimide resin film and method for producing same, laminate, and electronic device and method for producing same 东丽株式会社 2022-04-29 CN disclosed
CN-113474156-A Polyamic acid resin composition, polyimide resin film and method for producing same, laminate, and electronic device and method for producing same 东丽株式会社 2021-10-01 CN disclosed
CN-1989099-B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases FUNDACAO OSWALDO CRUZ 2013-10-30 CN disclosed
EP-1831153-A2 COMPOUNDS DERIVED FROM LIDOCAINE, PHARMACEUTICAL COMPOSITIONS, USE AND METHOD OF TREATMENT, PREVENTION OR INHIBITION OF DISEASES FUNDA AO OSWALDO CRUZ-FIOCRUZ (BR) 2007-09-12 EP disclosed
CN-1989099-A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases FUNDACAO OSWALDO CRUZ (BR) 2007-06-27 CN disclosed
WO-2005120148-A2 COMPOUNDS DERIVED FROM LIDOCAINE, PHARMACEUTICAL COMPOSITIONS, USE AND METHOD OF TREATMENT, PREVENTION OR INHIBITION OF DISEASES FUNDAÇÃO OSWALDO CRUZ-FIOCRUZ (BR) 2005-12-22 WO disclosed